Hepatic Cell News 2.48 December 14, 2018 | |
| |
TOP STORYScientists showed that a vagus-macrophage-hepatocyte link regulates acute liver regeneration after liver injury and that this system is critical for promoting survival. Hepatic Foxm1 is rapidly upregulated after partial hepatectomy. Hepatic branch vagotomy suppresses this upregulation and hepatocyte proliferation, thereby increasing mortality. [Nat Commun] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Researchers studied the role of hepatitis B virus X protein (HBx) expression on the progression of cell cycle and liver polyploidization during proliferation and liver carcinogenesis. Full-length HBx transgenic mice were developed to investigate liver ploidy as well as hepatocyte proliferation, along normal liver maturation and during cancer initiation (chemical carcinogen treatment). [Oncogene] Abstract Adipose-secreted circRNAs were found to regulate deubiquitination in hepatocellular carcinoma (HCC), thus facilitating cell growth. It was observed that exosome circ-deubiquitination (circ-DB) is upregulated in HCC patients with higher body fat ratios. In vitro and in vivo studies showed that exo-circ-DB promotes HCC growth and reduces DNA damage via the suppression of miR-34a and the activation of deubiquitination-related USP7. [Oncogene] Full Article The expression levels of lncRNA SNHG8 were dramatically increased in hepatocellular carcinoma (HCC) tissues and cell lines as compared with the adjacent normal tissues, and SNHG8 expression was an independent prognostic factor of tumor recurrence in HCC patients. [Cell Physiol Biochem] Full Article Resveratrol Ameliorates Lipid Droplet Accumulation in Liver through a SIRT1/ATF6-Dependent Mechanism There was a significant increase in the accumulation of lipid droplets (LD) in liver and hepatocytes during the process of high-fat diet-induced steatosis, respectively, which was significantly inhibited by resveratrol (RSV) supplementation. RSV notably activated SIRT1 expression and decreased the expression levels of ATF6, Fsp27β/CIDEC, CREBH, and PLIN1, which are associated with LD accumulation. [Cell Physiol Biochem] Full Article Investigators found that delphinidin inhibits morphological changes from epithelial to mesenchymal phenotype by epidermal growth factor (EGF). Delphinidin increased the messenger RNA and protein expression of E-cadherin and decreased those of Vimentin and Snail in EGF-induced hepatocellular carcinoma cells. [J Cell Biochem] Abstract For in vitro studies, palmitic acid and free fatty acid induced HepG2 and HL7702 steatosis cell models were used. For in vivo studies, NASH was induced by feeding mice MCD diet. These mice received either placebo or LH at three different doses for 6 weeks. [Biomed Pharmacother] Full Article Results of the MTT method indicated that GNA increased the chemosensitivity of doxorubicin (DOX) and paclitaxel in the HepG2/Adr cells and promoted the cell apoptosis in the presence of DOX. It also increased the retention of P-gp substrates DOX and Rhodamine 123 while did not affect the ATPase activity. [Biochem Biophys Res Commun] Abstract TGF-β1 caused the down-regulation of the miR-454 in hepatic stellate cells (HSC)-T6 cells. miR-454 inhibited the activation and proliferation of HSC-T6 cells. Wnt10a had a targeting relationship with miR-454. TGF-β1 promoted HSC-T6 activation and proliferation via down-regulating miR-454 expression, which further up-regulated Wnt10a expression. [J Biochem] Abstract Subscribe to one of our other 19 science newsletters such as Intestinal Cell News & Pancreatic Cell News. | |
| |
REVIEWSThe Roles of lncRNA in Hepatic Fibrosis Hepatic fibrosis is a continuous wound-healing process caused by numerous chronic hepatic diseases, and the activation of hepatic stellate cells is generally considered to be a pivotal step in hepatic fibrosis. [Cell Biosci] Full Article Visit our reviews page to see a complete list of reviews in the hepatic cell research field. | |
| |
INDUSTRY NEWSPerspectum Diagnostics and the SC Liver Research Consortium announce a collaboration to advance clinical development of investigational therapies. [Perspectum Diagnostics] Press Release Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced a collaborative research agreement with the Icahn School of Medicine at Mount Sinai in New York City. [Can-Fite BioPharma Ltd] Press Release | |
Take a look at hepatic organoids, their culture and applications. Learn More | |
| |
POLICY NEWSSouth Korean Scientists Protest Treatment of University President Accused of Misusing Funds Researchers in South Korea have criticized the nation’s science ministry for its handling of an investigation into the president of the Korea Advanced Institute of Science and Technology (KAIST) in Daejon, the country’s top technical university. The science ministry alleges that KAIST leader Shin Sung-Chul made illegal payments to a California lab, but many scientists see a political purge. [Nature News] Editorial The End of DACA Would Be a Blow to Science With the end of Deferred Action for Childhood Arrivals (DACA), undocumented scientists will lose what few protections they currently have under immigrant law, lose their access to their scientific research, and once again live in fear, as they are caught in legal limbo. [Scientific American] Editorial
| |
EVENTSNEW 2019 ASCO Annual Meeting Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Liver Disease (University of Illinois) Research Associate – Cancer Research (University of Cambridge) Research Associate – Cancer Structural Biology (University of British Columbia) Postdoctoral Position – Cancer Biology (Fox Chase Cancer Center) PhD Position – Non-Alcoholic Fatty Liver Disease (Deutsche Diabetes Forschungsgesellschaft e. V) Postdoctoral Researcher – Alcohol-Induced Liver Injury (Indiana University) Postdoctoral Position – Molecular & Integrative Physiology (University of Michigan) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Hepatic Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|